Amino acid substitutions in the effector domain of the γ134.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-α

Virology

Volumn 307, Issue 2, 2003, Pages 290-300

  Cerveny, Melissa ^a   Hessefort, Suzanne ^b   Yang, Kui ^a   Cheng, Guofeng ^a   Gross, Martin ^b   He, Bin ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INITIATION FACTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN GAMMA 1 34 5; TRANSLATION INITIATION FACTOR 2ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS RESISTANCE;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0344405787     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(02)00075-2     Document Type: Article

References (39)

1. Arao Y., Ando Y., Narita M., Kurata T. Unexpected correlation in the sensitivity of 19 herpes simplex virus strains to types I and II interferons. J. Interferon Cytokine Res. 17:(9):1997;537-541.
2. Bower J.R., Mao H., Durishin C., Rozenbom E., Detwiler M., Rempinski D., Karban T.L., Rosenthal K.S. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness. J. Virol. 73:(5):1999;3843-3853.
3. Brown S.M., MacLean A.R., McKie E.A., Harland J. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. J. Virol. 71:(12):1997;9442-9449.
4. 134.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-α/β Virology. 290:2001;115-120.
5. Cheng G., Gross M., Brett M.E., He B. AlaArg motif in the carboxyl terminus of the gamma(1)34.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2α J. Virol. 75:(8):2001;3666-3674.
6. 134.5 protein of herpes simplex virus type 1. J. Virol. 76:2002;9434-9445.
7. 134.5 mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA. 92:(23):1995;10516-10520.
8. 134.5, a gene nonessential for growth in culture. Science. 250:1990;1262-1266.
9. Chou J., Roizman B. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J. Virol. 57:(2):1986;629-637.
10. Chou J., Roizman B. The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J. Virol. 64:(3):1990;1014-1020.
11. 134.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA. 89:(8):1992;3266-3270.
12. 134.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc. Natl. Acad. Sci. USA. 91:(12):1994;5247-5251.
13. Cohen P.T. Protein phosphatase 1 - targeted in many directions. J. Cell Sci. 115:(Pt 2):2002;241-256.
14. Egloff M.P., Johnson D.F., Moorhead G., Cohen P.T., Cohen P., Barford D. Structural basis for the recognition of regulatory subunits by the catalytic subunit of protein phosphatase 1. EMBO J. 16:(8):1997;1876-1887.
15. Eidson K.M., Hobbs W.E., Manning B.J., Carlson P., DeLuca N.A. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76:(5):2002;2180-2191.
16. Ejercito P.M., Kieff E.D., Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J. Gen. Virol. 2:(3):1968;357-364.
17. Gale M. Jr., Katze M.G. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:(1):1998;29-46.
18. Harle P., Cull V., Agbaga M.P., Silverman R., Williams B.R., James C., Carr D.J. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76:(13):2002;6558-6567.
19. Harle P., Sainz B. Jr., Carr D.J., Halford W.P. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology. 293:(2):2002;295-304.
20. 134.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:(1):1996;84-90.
21. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 94:(3):1997;843-848.
22. 134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J. Biol. Chem. 273:(33):1998;20737-20743.
23. Horsburgh B.C., Hubinette M.M., Qiang D., MacDonald M.L., Tufaro F. Allele replacement an application that permits rapid manipulation of herpes simplex virus type 1 genomes . Gene Ther. 6:(5):1999;922-930.
24. Khabar K.S., Dhalla M., Siddiqui Y., Zhou A., Al-Ahdal M.N., Der S.D., Silverman R.H., Williams B.R. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes . J. Interferon Cytokine Res. 20:(7):2000;653-659.
25. Leib D.A., Harrison T.E., Laslo K.M., Machalek M.A., Moorman N.J., Virgin H.W. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:(4):1999;663-672.
26. Leib D.A., Machalek M.A., Williams B.R., Silverman R.H., Virgin H.W. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA. 97:(11):2000;6097-6101.
27. Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J. Virol. 75:(2):2001;750-758.
28. Mossman K.L., Saffran H.A., Smiley J.R. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74:(4):2000;2052-2056.
29. Mossman K.L., Smiley J.R. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:(4):2002;1995-1998.
30. Nicholl M.J., Robinson L.H., Preston C.M. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J. Gen. Virol. 81:(Pt 9):2000;2215-2218.
31. Oberman F., Panet A. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J. Gen. Virol. 69:(Pt 6):1988;1167-1177.
32. Preston C.M., Harman A.N., Nicholl M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J. Virol. 75:(19):2001;8909-8916.
33. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55:2001;255-281.
34. Sheldrick P., Berthelot N. Inverted repetitions in the chromosome of herpes simplex virus. Cold Spring Harb. Symp. Quant. Biol. 39:(Pt 2):1975;667-678.
35. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
36. 134.5 and UL41 genes of herpes simplex virus 1. J. Virol. 76:(14):2002;6974-6986.
37. Valyi-Nagy T., Fareed M.U., O'Keefe J.S., Gesser R.M., MacLean A.R., Brown S.M., Spivack J.G., Fraser N.W. The herpes simplex virus type 1 strain 17+ γ34.5 deletion mutant 1716 is avirulent in SCID mice. J. Gen. Virol. 75:(Pt 8):1994;2059-2063.
38. Wadsworth S., Jacob R.J., Roizman B. Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions. J. Virol. 15:(6):1975;1487-1497.
39. Yokota S., Yokosawa N., Kubota T., Suzutani T., Yoshida I., Miura S., Jimbow K., Fujii N. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology. 286:(1):2001;119-124.